http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2717674-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d975026b56be0a4316632ea65ea3112f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2017-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8545784f5cf7a9ecad11786149185a1a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a15752017181c7c3d4931be6972d0c1b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_528e9b9f279d5b0e5fec95d505d2665f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ba7a7d90630b28309a83e506af8d912 |
| publicationDate | 2020-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2717674-C1 |
| titleOfInvention | Therapeutic agent for enhancing tissue oxygenation in diabetic foot, and a method for use thereof |
| abstract | FIELD: medicine; pharmaceutics.SUBSTANCE: group of inventions refers to medicine and to pharmacy. Disclosed is the use of the dipeptide L-glutamine-L-tryptophanic acid (L-Glu-L-Trp) as an agent for enhancing tissue oxygenation by suppressing (reducing synthesis) of the HIF-1α factor in the diabetic foot. Disclosed is a method of enhancing tissue oxygenation by suppressing (reducing synthesis) of a HIF-1α factor in a diabetic foot consisting in local administration of a dipeptide L-glutamine-L-tryptophanic acid (L-Glu-L-Trp) in dose of 1.0–10.0 mcg/kg of body weight at least once a day for a period required to achieve a therapeutic effect.EFFECT: technical result consists in the implementation of the declared applications in the treatment of the diabetic foot in diabetic patients.3 cl, 9 tbl, 5 ex |
| priorityDate | 2017-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 153.